FDAnews
www.fdanews.com/articles/134557-neoprobe-licenses-imaging-technology-from-naviscan

Neoprobe Licenses Imaging Technology From Naviscan

February 24, 2011
Dublin, Ohio-based Neoprobe will use Naviscan’s technology in conjunction with its own gamma-detection systems, which are used to evaluate the potential spread of cancer to lymph node tissues and organs, according to a statement from San Diego-based Naviscan.
Med City News